Matches in Wikidata for { <http://www.wikidata.org/entity/Q93015279> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- Q93015279 description "2018 թվականի նոյեմբերի 12-ին հրատարակված գիտական հոդված" @default.
- Q93015279 description "article scientifique publié en 2018" @default.
- Q93015279 description "artículu científicu espublizáu en payares de 2018" @default.
- Q93015279 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93015279 description "scientific article published on 12 November 2018" @default.
- Q93015279 description "wetenschappelijk artikel" @default.
- Q93015279 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q93015279 name "Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts" @default.
- Q93015279 name "Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts" @default.
- Q93015279 type Item @default.
- Q93015279 label "Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts" @default.
- Q93015279 label "Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts" @default.
- Q93015279 prefLabel "Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts" @default.
- Q93015279 prefLabel "Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts" @default.
- Q93015279 P1433 Q93015279-80A8CB98-2FD5-4BF7-9EDD-21714299244E @default.
- Q93015279 P1476 Q93015279-3FC8CD68-23E8-4D11-98AB-277FBE2ACC04 @default.
- Q93015279 P2093 Q93015279-4E9583CD-2E04-4902-8761-FB24708B3295 @default.
- Q93015279 P2093 Q93015279-5E5B7B70-4938-4A64-ACAF-DFFE9D8E4012 @default.
- Q93015279 P2093 Q93015279-6536B536-7BDC-45F6-8C3B-2B40553D236E @default.
- Q93015279 P2093 Q93015279-8469EE07-F033-4120-A690-3421F9B321FB @default.
- Q93015279 P2093 Q93015279-9078D214-9E55-4FF0-921B-DD2FEC8B7DAC @default.
- Q93015279 P2093 Q93015279-E90FCC3C-0676-4991-8201-387E10C9DD52 @default.
- Q93015279 P2093 Q93015279-FC82338C-9573-488D-97D3-382AB32E3372 @default.
- Q93015279 P2860 Q93015279-17A2FA88-0C1C-453D-82BB-C16C53CBE6A5 @default.
- Q93015279 P2860 Q93015279-2DA16933-D93C-4958-8483-1ECD34BDD86D @default.
- Q93015279 P2860 Q93015279-3D692887-A58F-457C-B492-7F2B229CBB8B @default.
- Q93015279 P2860 Q93015279-3FB57061-E5B6-4872-8367-390EEAF5E2A9 @default.
- Q93015279 P2860 Q93015279-3FF659EA-BC03-41D8-9D3C-9905F26790CE @default.
- Q93015279 P2860 Q93015279-5BD50B15-D943-41A9-B0F7-9DB4F1E52A8E @default.
- Q93015279 P2860 Q93015279-697074DD-AE9C-4C30-9BC4-B9BC7AD39B33 @default.
- Q93015279 P2860 Q93015279-86AA7DD1-8BDE-43E8-BB93-67008F998D78 @default.
- Q93015279 P2860 Q93015279-8B952F53-816D-4859-B094-9EB0C6508F56 @default.
- Q93015279 P2860 Q93015279-8D238D52-7FDF-4104-BBA0-A507F876EE33 @default.
- Q93015279 P2860 Q93015279-959860FA-563F-4F58-803F-0463C0E6BF4A @default.
- Q93015279 P2860 Q93015279-9FDA5399-E320-43E2-BB05-13D7BA8555C9 @default.
- Q93015279 P2860 Q93015279-A4976082-92D9-4F70-A8AF-0DE21331C216 @default.
- Q93015279 P2860 Q93015279-AE96E226-F076-4678-8690-4F527DE5DA0E @default.
- Q93015279 P2860 Q93015279-BA6E5E9F-5C6B-4410-872B-9833F23BE603 @default.
- Q93015279 P2860 Q93015279-BB0E5855-80DA-4C26-9F10-7EEB73E2AD25 @default.
- Q93015279 P2860 Q93015279-C7339EE5-B433-4124-94A9-3DAFC2B3EE11 @default.
- Q93015279 P2860 Q93015279-CBF3DF97-81BA-4C27-98CE-771A0D8669F6 @default.
- Q93015279 P2860 Q93015279-CCD60804-7BE6-423F-BE1A-EFDD61D20B31 @default.
- Q93015279 P2860 Q93015279-D22495D1-B61A-4762-8A5E-D034A3144B97 @default.
- Q93015279 P2860 Q93015279-D8266A14-C564-4D9D-80E4-59690047E889 @default.
- Q93015279 P2860 Q93015279-E230976A-8E72-40AF-B691-B07404D461DE @default.
- Q93015279 P2860 Q93015279-E52B56B1-EF98-4FF0-B069-B21E22CDD016 @default.
- Q93015279 P304 Q93015279-12F7968D-8BEA-45C5-8D0F-FA4AAEAB8BDD @default.
- Q93015279 P31 Q93015279-90D02D83-A943-4755-95BF-0569042F6906 @default.
- Q93015279 P356 Q93015279-3907B497-E262-4090-B53A-1E8CA0F9A283 @default.
- Q93015279 P433 Q93015279-46389E1C-D964-4A19-A904-3707299AF9DB @default.
- Q93015279 P478 Q93015279-F7F3DA7C-D382-400F-948A-BD4F37B478F5 @default.
- Q93015279 P50 Q93015279-56EEDC98-8655-4E39-B4AF-8FD132FC76C3 @default.
- Q93015279 P577 Q93015279-DEF54BD1-0380-4B46-8599-71D934E504A0 @default.
- Q93015279 P698 Q93015279-F910E7FE-1EAA-40E0-A80D-FEAE544A05DE @default.
- Q93015279 P921 Q93015279-7721103D-A736-4743-A8D3-749DC78E8901 @default.
- Q93015279 P932 Q93015279-189526BD-0632-46C4-A684-B73D8965F8B9 @default.
- Q93015279 P356 GUTJNL-2018-317021 @default.
- Q93015279 P698 30420398 @default.
- Q93015279 P1433 Q5621669 @default.
- Q93015279 P1476 "Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts" @default.
- Q93015279 P2093 "Berkeley N Limketkai" @default.
- Q93015279 P2093 "Camilla Bjørn Jensen" @default.
- Q93015279 P2093 "Jean-Frederic Colombel" @default.
- Q93015279 P2093 "Manasi Agrawal" @default.
- Q93015279 P2093 "Ryan C Ungaro" @default.
- Q93015279 P2093 "Thomas Ullman" @default.
- Q93015279 P2093 "Tine Jess" @default.
- Q93015279 P2860 Q24245033 @default.
- Q93015279 P2860 Q34112953 @default.
- Q93015279 P2860 Q34420368 @default.
- Q93015279 P2860 Q37306060 @default.
- Q93015279 P2860 Q38064743 @default.
- Q93015279 P2860 Q38369506 @default.
- Q93015279 P2860 Q38433080 @default.
- Q93015279 P2860 Q38588669 @default.
- Q93015279 P2860 Q40324736 @default.
- Q93015279 P2860 Q40609049 @default.
- Q93015279 P2860 Q40951654 @default.
- Q93015279 P2860 Q41990807 @default.
- Q93015279 P2860 Q43225982 @default.
- Q93015279 P2860 Q43787576 @default.
- Q93015279 P2860 Q44048310 @default.
- Q93015279 P2860 Q44347539 @default.
- Q93015279 P2860 Q46718223 @default.
- Q93015279 P2860 Q46732750 @default.
- Q93015279 P2860 Q50089697 @default.
- Q93015279 P2860 Q74672515 @default.
- Q93015279 P2860 Q87263251 @default.
- Q93015279 P2860 Q88899916 @default.
- Q93015279 P2860 Q89170863 @default.
- Q93015279 P304 "977-984" @default.
- Q93015279 P31 Q13442814 @default.
- Q93015279 P356 "10.1136/GUTJNL-2018-317021" @default.
- Q93015279 P433 "6" @default.
- Q93015279 P478 "68" @default.
- Q93015279 P50 Q56457877 @default.
- Q93015279 P577 "2018-11-12T00:00:00Z" @default.
- Q93015279 P698 "30420398" @default.
- Q93015279 P921 Q1477 @default.
- Q93015279 P932 "7057119" @default.